Hedy Kindler
University of Chicago Comprehensive Cancer Center
6
6
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Caio Rocha Lima, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Worked with same sponsors:
Hedy Kindler
University of Chicago
Shared therapeutic areas:
Worked with same sponsors:
Betty Ferrell
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Wen Wee Ma
Roswell Park Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Virginia Sun
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Stephen Michael Hahn
Abramson Cancer Center at Penn Medicine
Shared therapeutic areas:
Worked with same sponsors:
Crystal Denlinger, MD
Fox Chase Cancer Center
Shared therapeutic areas:
Vincent Chung
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Manish Sharma
University of Chicago Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Lakshmi Rajdev
ECOG-ACRIN Cancer Research Group
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma
Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma
All 6 trials loaded